MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population
Autor: | Zhiwen Li, Aiyu Lin, Fang Liu, Jiting Zhu, Xuan Wu, Jianglong Chen, Xiaoping Yao, Zeng Wang, Weidong Zheng |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Adult Male medicine.medical_specialty Multiple Sclerosis Disease Nucleic Acid Denaturation Gastroenterology Diagnosis Differential 03 medical and health sciences 0302 clinical medicine Text mining Multiple Sclerosis Relapsing-Remitting Asian People Clinical Research Internal medicine microRNA medicine Humans Spectrum disorder Whole blood Neuromyelitis optica business.industry Multiple sclerosis Neuromyelitis Optica General Medicine Middle Aged medicine.disease MicroRNAs 030104 developmental biology Gene Expression Regulation Female Differential diagnosis business 030217 neurology & neurosurgery Signal Transduction |
Zdroj: | Medical Science Monitor : International Medical Journal of Experimental and Clinical Research |
ISSN: | 1643-3750 1234-1010 |
Popis: | BACKGROUND Recent studies identified a set of differentially expressed miRNAs in whole blood that may discriminate neuromyelitis optica spectrum disorders (NMOSD) from relapsing-remitting multiple sclerosis (RRMS). This study invalidated 9 known miRNAs in Chinese patients. MATERIAL AND METHODS The levels of miRNAs in whole blood were assayed in healthy controls (n=20) and patients with NMOSD (n=45), RRMS (n=17) by quantitative real-time polymerase chain reaction (qRT-PCR), and pairwise-compared between groups. They were further analyzed for association with clinical features and MRI findings of the diseases. RESULTS Compared with healthy controls, miR-22b-5p, miR-30b-5p and miR-126-5p were down-regulated in NMOSD, in contrast, both miR-101-5p and miR-126-5p were up-regulated in RRMS. Moreover, the levels of miR-101-5p, miR-126-5p and miR-660-5p, were significantly higher in RRMS than in NMOSD (P=0.04, 0.01 and 0.02, respectively). The level of miR-576-5p was significantly higher in patients underwent relapse for ≤3 times than those for ≥4 times. In addition, its level was significantly higher in patients suffered from a severe visual impairment (visual sight ≤0.1). Moreover, the levels of each of the 9 miRNAs were lower in NMOSD patients with intracranial lesions (NMOSD-IC) than those without (NMOSD-non-IC). Despite correlations of miRNAs with these disease subtypes, all AUCs of ROC generated to discriminate patients and controls, as well as intracranial lesions, were |
Databáze: | OpenAIRE |
Externí odkaz: |